Mycophenolic Acid
NDC 70436-172, Mycophenolic Acid, tablet, delayed release, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-172
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214376
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MYCOPHENOLATE SODIUM180 mg/1
Pharmacologic classes
Antimetabolite Immunosuppressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-172-23 | 70436017223 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (70436-172-23) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c1ce92ef-4102-1487-e053-2995a90ac521Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70436-172
Use it
Look up 70436-172 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-172. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.